Route of immunization and the therapeutic impact of recombinant anticancer vaccines.

Journal of the National Cancer Institute ·Vol. 89 ·No. 5 ·1997-03-05 ·Pages 390-2

Irvine KR, Chamberlain RS, Shulman EP, Rosenberg SA, Restifo NP

Abstract

暂无摘要

MeSH Terms

Animals Cancer Vaccines/administration & dosage Humans Injections, Intramuscular Injections, Intravenous Neoplasms/prevention & control Neoplasms, Experimental/prevention & control Recombinant Proteins/administration & dosage

Chemicals

Cancer Vaccines Recombinant Proteins

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Irvine K R

Surgery Branch, National Cancer Institute, Bethesda, MD, USA.

Chamberlain R S

Shulman E P

Rosenberg S A

Restifo N P

Article Info

Journal

Journal of the National Cancer Institute

Abbr.

J Natl Cancer Inst

ISSN

0027-8874

DOI

10.1093/jnci/89.5.390

Published

1997-03-05

Pages

390-2

Language

English

Region

United States

NLM ID

7503089

Subset

Grants

Intramural NIH HHS · Z01 BC010763-01 · United States

Intramural NIH HHS · Z99 CA999999 · United States

External Links

PubMed source DOI: 10.1093/jnci/89.5.390 View journal details

Analysis Services

Route of immunization and the therapeutic impact of recombinant anticancer vaccines.

Contact

WeChat Official Account